Skip to contentG
Gossamer Bio, Inc.
G
GOSSGossamer Bio, Inc. Q2 2023 · 10-Q
Revenue$0.00$0.00no prior Q2 2022 on file Net Income-$42.50M-$42.50MN/M vs Q2 2022 EPS Diluted-$0.45-$0.45N/M vs Q2 2022 Operating Income-$46,300,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$38,251,000N/M ended Jun 30, 2023 · filed Aug 8, 2023 · 39 d after period end